Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24))

Rafal Goraczniak; Brian A. Wall; Mark A. Behlke; Kim A. Lennox; Eric S. Ho; Nikolas H. Zaphiros; Christopher Jakubowski; Neil R. Patel; Steven Zhao; Carlo Magaway; Stacey A. Subbie; Lumeng Jenny Yu; Stephanie LaCava; Kenneth R. Reuhl; Suzie Chen; Samuel I. Gunderson

doi:10.1016/j.omtn.2024.102403

Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24))

Rafal Goraczniak, Brian A. Wall, Mark A. Behlke, Kim A. Lennox, Eric S. Ho, Nikolas H. Zaphiros, Christopher Jakubowski, Neil R. Patel, Steven Zhao, Carlo Magaway, Stacey A. Subbie, Lumeng Jenny Yu, Stephanie LaCava, Kenneth R. Reuhl, Suzie Chen, Samuel I. Gunderson

Rutgers, The State University

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

(Molecular Therapy–Nucleic Acids 2, e92; 2013) In the originally published version of this article, the wrong images were used in the upper Figure 5B RGD-G5 panel and the upper Figure 5C RGD-G5 panel. Wrong images were also used in Figure 2D, BCL2-A/TDmt lower panel (100× zoom); Figure 5B, GRM1-Aps/TDmt lower panel (100× zoom); and Figure 5C, GRM1-Aps lower panel (100× zoom). These errors were in including the wrong images, not in the quantification that now correctly corresponds to the new images. Thus, the overall conclusions from Figures 2 and 5 are unchanged. The authors apologize for any confusion.[Figure

Original language	American English
Article number	102403
Journal	Molecular Therapy Nucleic Acids
Volume	36
Issue number	1
DOIs	https://doi.org/10.1016/j.omtn.2024.102403
State	Published - Mar 11 2025

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

Access to Document

10.1016/j.omtn.2024.102403

Fingerprint

Dive into the research topics of 'Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24))'. Together they form a unique fingerprint.

Cite this

Goraczniak, R., Wall, B. A., Behlke, M. A., Lennox, K. A., Ho, E. S., Zaphiros, N. H., Jakubowski, C., Patel, N. R., Zhao, S., Magaway, C., Subbie, S. A., Yu, L. J., LaCava, S., Reuhl, K. R., Chen, S., & Gunderson, S. I. (2025). Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24)). Molecular Therapy Nucleic Acids, 36(1), Article 102403. https://doi.org/10.1016/j.omtn.2024.102403

Goraczniak, Rafal ; Wall, Brian A. ; Behlke, Mark A. et al. / Erratum : U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24)). In: Molecular Therapy Nucleic Acids. 2025 ; Vol. 36, No. 1.

@article{a9454014595d43a99792d0b7de514522,

title = "Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24))",

abstract = "(Molecular Therapy–Nucleic Acids 2, e92; 2013) In the originally published version of this article, the wrong images were used in the upper Figure 5B RGD-G5 panel and the upper Figure 5C RGD-G5 panel. Wrong images were also used in Figure 2D, BCL2-A/TDmt lower panel (100× zoom); Figure 5B, GRM1-Aps/TDmt lower panel (100× zoom); and Figure 5C, GRM1-Aps lower panel (100× zoom). These errors were in including the wrong images, not in the quantification that now correctly corresponds to the new images. Thus, the overall conclusions from Figures 2 and 5 are unchanged. The authors apologize for any confusion.[Figure",

author = "Rafal Goraczniak and Wall, {Brian A.} and Behlke, {Mark A.} and Lennox, {Kim A.} and Ho, {Eric S.} and Zaphiros, {Nikolas H.} and Christopher Jakubowski and Patel, {Neil R.} and Steven Zhao and Carlo Magaway and Subbie, {Stacey A.} and Yu, {Lumeng Jenny} and Stephanie LaCava and Reuhl, {Kenneth R.} and Suzie Chen and Gunderson, {Samuel I.}",

note = "Publisher Copyright: {\textcopyright} 2024 American Society of Gene & Cell Therapy",

year = "2025",

month = mar,

day = "11",

doi = "10.1016/j.omtn.2024.102403",

language = "American English",

volume = "36",

journal = "Molecular Therapy Nucleic Acids",

issn = "2162-2531",

publisher = "Cell Press",

number = "1",

}

Goraczniak, R, Wall, BA, Behlke, MA, Lennox, KA, Ho, ES, Zaphiros, NH, Jakubowski, C, Patel, NR, Zhao, S, Magaway, C, Subbie, SA, Yu, LJ, LaCava, S, Reuhl, KR, Chen, S & Gunderson, SI 2025, 'Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24))', Molecular Therapy Nucleic Acids, vol. 36, no. 1, 102403. https://doi.org/10.1016/j.omtn.2024.102403

Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24)). / Goraczniak, Rafal; Wall, Brian A.; Behlke, Mark A. et al.
In: Molecular Therapy Nucleic Acids, Vol. 36, No. 1, 102403, 11.03.2025.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24))

AU - Goraczniak, Rafal

AU - Wall, Brian A.

AU - Behlke, Mark A.

AU - Lennox, Kim A.

AU - Ho, Eric S.

AU - Zaphiros, Nikolas H.

AU - Jakubowski, Christopher

AU - Patel, Neil R.

AU - Zhao, Steven

AU - Magaway, Carlo

AU - Subbie, Stacey A.

AU - Yu, Lumeng Jenny

AU - LaCava, Stephanie

AU - Reuhl, Kenneth R.

AU - Chen, Suzie

AU - Gunderson, Samuel I.

PY - 2025/3/11

Y1 - 2025/3/11

N2 - (Molecular Therapy–Nucleic Acids 2, e92; 2013) In the originally published version of this article, the wrong images were used in the upper Figure 5B RGD-G5 panel and the upper Figure 5C RGD-G5 panel. Wrong images were also used in Figure 2D, BCL2-A/TDmt lower panel (100× zoom); Figure 5B, GRM1-Aps/TDmt lower panel (100× zoom); and Figure 5C, GRM1-Aps lower panel (100× zoom). These errors were in including the wrong images, not in the quantification that now correctly corresponds to the new images. Thus, the overall conclusions from Figures 2 and 5 are unchanged. The authors apologize for any confusion.[Figure

AB - (Molecular Therapy–Nucleic Acids 2, e92; 2013) In the originally published version of this article, the wrong images were used in the upper Figure 5B RGD-G5 panel and the upper Figure 5C RGD-G5 panel. Wrong images were also used in Figure 2D, BCL2-A/TDmt lower panel (100× zoom); Figure 5B, GRM1-Aps/TDmt lower panel (100× zoom); and Figure 5C, GRM1-Aps lower panel (100× zoom). These errors were in including the wrong images, not in the quantification that now correctly corresponds to the new images. Thus, the overall conclusions from Figures 2 and 5 are unchanged. The authors apologize for any confusion.[Figure

UR - http://www.scopus.com/inward/record.url?scp=85212586397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85212586397&partnerID=8YFLogxK

U2 - 10.1016/j.omtn.2024.102403

DO - 10.1016/j.omtn.2024.102403

M3 - Comment/debate

SN - 2162-2531

VL - 36

JO - Molecular Therapy Nucleic Acids

JF - Molecular Therapy Nucleic Acids

IS - 1

M1 - 102403

ER -

Goraczniak R, Wall BA, Behlke MA, Lennox KA, Ho ES, Zaphiros NH et al. Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24)). Molecular Therapy Nucleic Acids. 2025 Mar 11;36(1):102403. doi: 10.1016/j.omtn.2024.102403

Erratum: U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo (2013) 2 (1–13), (S2162253116301548), (10.1038/mtna.2013.24))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this